rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

500359 RANBAXY Group (A)

Ranbaxy Laboratories Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
711.40   25.65   3.74%
Volume 70,107
Prev close 685.75
Day's H/L (Rs.) 717.90 - 680.50
52wk H/L (Rs.) 746.00 - 335.00
Mkt Cap (Rs. Cr) 30,284.30
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

RANBAXY

Ranbaxy Laboratories Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
712.05   24.35   3.54%
Volume 517,949
Prev close 687.70
Day's H/L (Rs.) 718.00 - 679.80
52wk H/L (Rs.) 746.50 - 335.00
Turnover (Rs. Lacs) 3,601.92
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Market Voices for Ranbaxy Laboratories Ltd.  (See all 1,981 market voices)   

140 Characters
  Cancel
Expert Voices - 1 day(s) ago
#Ranbaxy-Laboratories-Ltd
: Loses bid to overturn USFDA revocation of drug approvals. Co sought USFDA approval to make generic Nexium & Valcyte. Co sued USFDA revoking approval over plant problems. (ET Now)
Reply   |   Share
- 1 day ago  
#profitmantraa
Want To Earn Regular Profit with unique strategy cliCk here http://goo.gl/G9OEq1
Reply   |  Share
- 1 day ago  
#profitmantraa
Want To Earn Regular Profit with unique strategy cliCk here http://goo.gl/G9OEq1
Reply   |  Share
- 1 day ago  
#profitmantraa
Want To Earn Regular Profit with unique strategy cliCk here http://goo.gl/G9OEq1
Reply   |  Share
CHM - 18 hour(s) ago BUY for target of 740.
#Ranbaxy-Laboratories-Ltd
Reply   |   Share

Realtime news for Ranbaxy Laboratories Ltd. (See all 850 news)

01 March 2015, 09:57
Pharma shares gain; BSE Healthcare index up nearly 200 points - 18 hour(s) ago
US judge denies Ranbaxy to launch Valcyte, Nexium copy - 21 hour(s) ago
Largest human heart formed - 3 day(s) ago
United States : FTC's ruling allows SUN PHARMA to potentially close $4B merger deal with RANBAXY owner by mid-month [TendersInfo (India)] - 07 Feb 2015
US FTC grants conditional approval for Sun-Ranbaxy merger deal - 02 Feb 2015

BSE Announcements from Ranbaxy Laboratories Ltd. (See all)

Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992 - 20 Feb 2015
Shareholding Pattern For December 31, 2014 - 09 Jan 2015

Company details for Ranbaxy Laboratories Ltd.

Report Card

PE Ratios
-33.03
EPS (Rs.)
-20.76
Sales (Rs. Cr)
1,009.85
Face Value (Rs.)
5
Net Profit
Margin (%)
 
-11.49
Last Bonus
3:5
Last Dividend(%)
40
Return on
Average Equity
 
-80.16

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Ranbaxy Laboratories Ltd. performance snapshot

If you had invested Rs.  in Ranbaxy Laboratories Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Ranbaxy Laboratories Ltd. with other stocks

Apollo Hospitals Enterprise Ltd.
1,299.55
Cadila Healthcare Ltd.
1,509.45
Show more companies
Apollo Hospitals Enterprise Ltd.
1,299.55
Cadila Healthcare Ltd.
1,509.45
Ipca Laboratories Ltd.
666.65
Torrent Pharmaceuticals Ltd.
1,071.50
Piramal Enterprises Ltd.
910.70
Lupin Ltd.
1,702.75
GlaxoSmithKline Pharmaceuticals Ltd.
3,096.05
Aurobindo Pharma Ltd.
1,025.05
Biocon Ltd.
421.75
Natco Pharma Ltd.
1,335.25
Show less companies
Close
Add Ranbaxy Laboratories Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Ranbaxy Laboratories Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close